Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
Apply
AlloNK® & Rituximab
AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step